Company intelligence / Profile preview

Tepha

Lexington, Massachusetts, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Tepha’s P4HB-based GalaFLEX® and Phasix™ mesh products are commercial and widely used for soft tissue reinforcement, offering rapid tissue ingrowth and bioresorption; they enable effective soft tissue repair and are now part of BD’s surgical mesh portfolio.

Therapeutic areas: OtherRheumatology
Modalities: DevicePolymer-drug conjugate therapy
Industry: Surgical Medical Devices

Partnerships

BD (Becton, Dickinson and Company), strong partner and now parent

Beyond the preview

Go deeper on Tepha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tepha.

Explore the full profile